SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines. Learn more.
The promise of SonoThera’s technology and approach to gene therapy is inspiring. We’re building a platform to target multifactorial diseases. No one else on the planet is doing this.
Maria Konovalenko
Current Openings
Our values
Passionate
We act with urgency because patients are waiting.
Open-minded
We are truth seekers who incorporate diversity of thought
Collaboration
We believe everyone has a voice.
Rigor
We are data-driven and operate from the first principles of science.
Innovative & Fun
The work we do is serious, but we do not have to be serious people.
Resilience
Science is hard, but we are determined to persevere.